The Canadian Press 19/09/2024 15:06 The Nunavut government says it will provide immunization against respiratory syncytial virus to all infants in the territory this fall, a policy change that one pediatric infectious diseases specialist has been advocating for decades. “This new immunization program is vital because RSV … poses a significant health risk to infants,” Dr. Ekua Agyemang, Nunavut’s deputy chief medical officer of health, said in an email to The Canadian Press on Thursday. The territory will give infants Nirsevimab, a single-dose antibody injection with the brand name Beyfortus, that was authorized by Health Canada in April 2023. The antibody injection is approved for newborns and infants during their first RSV season, as well as children up to 24 months old who continue to be at risk of severe…
Register
